Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

OVERLAP
51%
OVERLAP
BY WEIGHT
10
# OF OVERLAPPING
HOLDINGS
MEDX
28
HOLDINGS
36%
ALSO IN PPH
PPH
26
HOLDINGS
43%
ALSO IN MEDX
SECTOR DRIFT (MEDX minus PPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in MEDX |
Weight in PPH |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 13.9% | 16.7% | 13.9% | |
NOVARTIS AG-ADR | 7.1% | 7.9% | 7.1% | |
JOHNSON & JOHNSON | 5.0% | 11.6% | 5.0% | |
ABBVIE INC | 9.4% | 5.0% | 5.0% | |
ASTRAZENECA PLC-SPONS ADR | 5.4% | 5.0% | 5.0% |
MEDX Overweight Relative to PPH
ALNYLAM PHARMACEUTICALS INC | 6.6% | |
ABBVIE INC | 4.4% | |
AMGEN INC | 4.0% | |
ALKERMES PLC | 4.0% | |
CRISPR THERAPEUTICS AG | 3.3% | |
IONIS PHARMACEUTICALS, INC. | 3.1% | |
BIOGEN IDEC INC | 2.5% | |
REGENERON PHARMACEUTICALS | 2.5% | |
GALECTIN THERAPEUTICS INC | 1.3% | |
BEAM THERAPEUTICS, INC. | 0.9% |
MEDX Underweight Relative to PPH
JOHNSON & JOHNSON | -6.6% | |
NOVO-NORDISK A/S-SPONS ADR | -6.1% | |
SANOFI-AVENTIS-ADR | -4.7% | |
MCKESSON CORP | -4.4% | |
ZOETIS INC | -4.3% | |
CENCORA INC | -3.7% | |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -2.9% | |
MERCK & CO. INC. | -2.9% | |
ELI LILLY & CO | -2.7% | |
GLAXOSMITHKLINE PLC-SPON ADR | -1.8% |